Related references
Note: Only part of the references are listed.Statin Reverses Smoke-induced Pulmonary Hypertension and Prevents Emphysema but Not Airway Remodeling
Joanne L. Wright et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Prognostic Impact of Hospital Readmissions After Primary Percutaneous Coronary Intervention
Gianluca Campo et al.
ARCHIVES OF INTERNAL MEDICINE (2011)
Increased Adverse Events After Percutaneous Coronary Intervention in Patients With COPD Insights From the National Heart, Lung, and Blood Institute Dynamic Registry
Jonathan R. Enriquez et al.
CHEST (2011)
Statin Therapy is Associated with Decreased Pulmonary Vascular Pressures in Severe COPD
Robert M. Reed et al.
COPD-JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (2011)
ESC/EAS GUIDELINES ESC/EAS Guidelines for the management of dyslipidaemias
Zeljko Reiner et al.
TURK KARDIYOLOJI DERNEGI ARSIVI-ARCHIVES OF THE TURKISH SOCIETY OF CARDIOLOGY (2011)
Chronic obstructive pulmonary disease: patho-physiology, current methods of treatment and the potential for simvastatin in disease management
Laura Marin et al.
EXPERT OPINION ON DRUG DELIVERY (2011)
Effect of heart rate reduction by ivabradine on left ventricular remodeling in the echocardiographic substudy of BEAUTIFUL
C. Ceconi et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2011)
Biochemical markers of cardiac dysfunction predict mortality in acute exacerbations of COPD
Catherina L. Chang et al.
THORAX (2011)
Elevated high-sensitivity cardiac troponin T is associated with increased mortality after acute exacerbation of chronic obstructive pulmonary disease
A. D. Hoiseth et al.
THORAX (2011)
Increased platelet activation in patients with stable and acute exacerbation of COPD
John D. Maclay et al.
THORAX (2011)
ESC/EAS Guidelines for the management of dyslipidaemias
Zeljko Reiner et al.
EUROPEAN HEART JOURNAL (2011)
Chronic obstructive pulmonary disease after myocardial infarction in the community
Francesca Bursi et al.
AMERICAN HEART JOURNAL (2010)
β-Blocker use following myocardial infarction: Low prevalence of evidence-based dosing
Jeffrey J. Goldberger et al.
AMERICAN HEART JOURNAL (2010)
Impact of Chronic Obstructive Pulmonary Disease on Acute-Phase Outcome of Myocardial Infarction
Kohei Wakabayashi et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
Lack of Effect of Oral Beta-Blocker Therapy at Discharge on Long-Term Clinical Outcomes of ST-Segment Elevation Acute Myocardial Infarction After Primary Percutaneous Coronary Intervention
Neiko Ozasa et al.
AMERICAN JOURNAL OF CARDIOLOGY (2010)
β-Blockers May Reduce Mortality and Risk of Exacerbations in Patients With Chronic Obstructive Pulmonary Disease
Frans H. Rutten et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
High Prevalence of Undiagnosed Airflow Limitation in Patients With Cardiovascular Disease
Joan B. Soriano et al.
CHEST (2010)
Increased Risk of Myocardial Infarction and Stroke Following Exacerbation of COPD
Gavin C. Donaldson et al.
CHEST (2010)
Prevalence and Prognosis of Chronic Obstructive Pulmonary Disease Among 8167 Middle Eastern Patients With Acute Coronary Syndrome
Hadi A. R. Hadi et al.
CLINICAL CARDIOLOGY (2010)
Guidelines on myocardial revascularization The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
William Wijns et al.
EUROPEAN HEART JOURNAL (2010)
Chronic obstructive pulmonary disease-An independent risk factor for long-term cardiac and cardiovascular mortality in patients with ischemic heart disease
Kei Nishiyama et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Effect of enalapril on exercise cardiopulmonary performance in chronic obstructive pulmonary disease: A pilot study
Fabiano Di Marco et al.
PULMONARY PHARMACOLOGY & THERAPEUTICS (2010)
Cardiovascular events in patients with COPD: TORCH Study results
Peter M. A. Calverley et al.
THORAX (2010)
Prevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary care
Johanna R. Feary et al.
THORAX (2010)
Chronic Obstructive Pulmonary Disease: Effects beyond the Lungs
Peter J. Barnes
PLOS MEDICINE (2010)
Characterisation of COPD heterogeneity in the ECLIPSE cohort
Alvar Agusti et al.
RESPIRATORY RESEARCH (2010)
Comparison of Men and Women With Acute Coronary Syndrome in Six Middle Eastern Countries
Ayman El-Menyar et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Current Use of Beta Blockers in Patients With Reactive Airway Disease Who Are Hospitalized With Acute Coronary Syndromes
Benjamin A. Olenchock et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial
Kim Fox et al.
EUROPEAN HEART JOURNAL (2009)
Chronic obstructive pulmonary disease is an independent predictor of death but not atherosclerotic events in patients with myocardial infarction: analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT)
Nathaniel M. Hawkins et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Systemic manifestations and comorbidities of COPD
P. J. Barnes et al.
EUROPEAN RESPIRATORY JOURNAL (2009)
Effects of chronic obstructive pulmonary disease on coronary atherosclerosis
Ramazan Topsakal et al.
HEART AND VESSELS (2009)
Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries
Kornelia Kotseva et al.
LANCET (2009)
Reducing mortality for chronic obstructive pulmonary disease: role of statins and angiotensin-converting enzyme inhibitors
Sabina A Antoniu
Expert Review of Pharmacoeconomics & Outcomes Research (2009)
Impact of statins and ACE inhibitors on mortality after COPD exacerbations
Eric M. Mortensen et al.
RESPIRATORY RESEARCH (2009)
Pharmacological actions of statins: potential utility in COPD
R. P. Young et al.
EUROPEAN RESPIRATORY REVIEW (2009)
Impact of cardioselective β-blockers on mortality in patients with chronic obstructive pulmonary disease and atherosclerosis
Yvette R. B. M. van Gestel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD
D. M. Mannino et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Troponin T elevation and long-term mortality after chronic obstructive pulmonary disease exacerbation
P. H. Brekke et al.
EUROPEAN RESPIRATORY JOURNAL (2008)
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
Kim Fox et al.
LANCET (2008)
Use of β blockers and the risk of death in hospitalised patients with acute exacerbations of COPD
M. T. Dransfield et al.
THORAX (2008)
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease - GOLD executive summary
Klaus F. Rabe et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee
Lorcan P. McGarvey et al.
THORAX (2007)
Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes
Adam C. Salisbury et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Systemic inflammation and mortality in chronic obstructive pulmonary disease
Don D. Sin et al.
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2007)
European guidelines on cardiovascular disease prevention in clinical practice: Full text
Ian Graham et al.
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION (2007)
Projections of global mortality and burden of disease from 2002 to 2030
Colin D. Mathers et al.
PLOS MEDICINE (2006)
Alveolar cell senescence in patients with pulmonary emphysema
Takao Tsuji et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Potential misclassification of causes of death from COPD
H. H. Jensen et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease
G. B. John Mancini et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Epidemiology and costs of chronic obstructive pulmonary disease
KR Chapman et al.
EUROPEAN RESPIRATORY JOURNAL (2006)
Guidelines on the management of stable angina pectoris: executive summary
Kim Fox et al.
EUROPEAN HEART JOURNAL (2006)
Inflammation markers predicting frailty and mortality in the elderly
Massimo De Martinis et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2006)
Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada cardiovascular disease in COPD patients
SM Curkendall et al.
ANNALS OF EPIDEMIOLOGY (2006)
Patterns of comorbidities in newly diagnosed COPD and asthma in primary care
JB Soriano et al.
CHEST (2005)
COPD and incident cardiovascular disease hospitalizations and mortality: Kaiser permanente medical care program
S Sidney et al.
CHEST (2005)
Chronic obstructive pulmonary disease as a predictor of mortality in patients undergoing percutaneous coronary intervention
CL Selvaraj et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Under-use of beta-blockers in patients with ischaemic heart disease and concomitant chronic obstructive pulmonary disease
M Egred et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2005)
Inflamm-ageing and lifelong antigenic load as major determinants of ageing rate and longevity
M De Martinis et al.
FEBS LETTERS (2005)
Relationships among bacteria, upper airway, lower airway, and systemic inflammation in COPD
JR Hurst et al.
CHEST (2005)
Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
S Yusuf et al.
LANCET (2004)
Importance of chronic obstructive pulmonary disease for prognosis and diagnosis of congestive heart failure in patients with acute myocardial infarction
E Kjoller et al.
EUROPEAN JOURNAL OF HEART FAILURE (2004)
Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease
DD Sin et al.
CIRCULATION (2003)
What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis
AL Hansell et al.
EUROPEAN RESPIRATORY JOURNAL (2003)
Cardioselective β-blockers in patients with reactive airway disease:: A meta-analysis
SR Salpeter et al.
ANNALS OF INTERNAL MEDICINE (2002)
Occurrence and prognostic significance of ventricular arrhythmia is related to pulmonary function -: A study from men born in 1914, Malmo, Sweden
G Engström et al.
CIRCULATION (2001)
Share Paper
